Suppr超能文献

系统性红斑狼疮患者外周血单个核细胞中Toll样受体mRNA表达上调。

Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

作者信息

Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R, Maki N, Hatakeyama T, Sawada K

机构信息

Third Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.

出版信息

Clin Exp Immunol. 2008 Jun;152(3):482-7. doi: 10.1111/j.1365-2249.2008.03646.x. Epub 2008 Mar 28.

Abstract

Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.

摘要

最近在系统性红斑狼疮(SLE)动物模型中的研究表明,Toll样受体(TLR - 7和TLR - 9)和干扰素(IFN)-α参与了小鼠狼疮的发病机制。最近使用流式细胞术的研究还表明,SLE患者外周血单个核细胞(PBMC)中TLR - 9的表达增加。在本研究中,我们对21例SLE患者和21名健康受试者的PBMC进行了定量实时逆转录 - 聚合酶链反应分析,以评估TLR2、TLR3、TLR4、TLR5、TLR7、TLR8、TLR9、IFN -α和LY6E(一种I型IFN诱导基因)的mRNA表达水平。SLE患者中TLR2、TLR7、TLR9、IFN -α和LY6E mRNA的表达水平显著高于健康对照。SLE患者中TLR7和TLR9 mRNA的表达水平与IFN -α mRNA的表达水平相关。这些结果表明,PBMC中TLR7和TLR9 mRNA的上调表达以及IFN -α mRNA表达的增加可能也参与了人类狼疮的发病机制。

相似文献

1
Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Clin Exp Immunol. 2008 Jun;152(3):482-7. doi: 10.1111/j.1365-2249.2008.03646.x. Epub 2008 Mar 28.
3
Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
Immunopharmacol Immunotoxicol. 2017 Feb;39(1):11-18. doi: 10.1080/08923973.2016.1263859. Epub 2017 Jan 3.
6
Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females.
Rheumatology (Oxford). 2014 Jan;53(1):48-55. doi: 10.1093/rheumatology/ket316. Epub 2013 Sep 24.
10

引用本文的文献

2
Female-bias in systemic lupus erythematosus: How much is the X chromosome to blame?
Biol Sex Differ. 2024 Oct 7;15(1):76. doi: 10.1186/s13293-024-00650-y.
3
Investigating the therapeutic mechanism of Jiedu-Quyu-Ziyin Fang on systemic lupus erythematosus through the ERα-miRNA-TLR7 immune axis.
Heliyon. 2024 Jun 8;10(12):e32752. doi: 10.1016/j.heliyon.2024.e32752. eCollection 2024 Jun 30.
4
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases.
Mol Med. 2023 Sep 4;29(1):117. doi: 10.1186/s10020-023-00717-3.
5
Ancestry-based differences in the immune phenotype are associated with lupus activity.
JCI Insight. 2023 Aug 22;8(16):e169584. doi: 10.1172/jci.insight.169584.
6
Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy.
Cell Rep Med. 2023 May 16;4(5):101036. doi: 10.1016/j.xcrm.2023.101036.
9
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.
Biomark Res. 2022 Dec 7;10(1):89. doi: 10.1186/s40364-022-00436-7.
10
Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
PLoS One. 2022 Apr 22;17(4):e0260565. doi: 10.1371/journal.pone.0260565. eCollection 2022.

本文引用的文献

1
Systemic lupus erythematosus.
Lancet. 2007 Feb 17;369(9561):587-96. doi: 10.1016/S0140-6736(07)60279-7.
3
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
Semin Immunol. 2007 Feb;19(1):11-23. doi: 10.1016/j.smim.2006.12.005. Epub 2007 Feb 2.
5
Toll-like receptors in systemic autoimmune disease.
Nat Rev Immunol. 2006 Nov;6(11):823-35. doi: 10.1038/nri1957.
6
Type-I interferons and systemic lupus erythematosus.
Autoimmun Rev. 2006 Oct;5(8):554-62. doi: 10.1016/j.autrev.2006.05.002. Epub 2006 Jun 27.
7
Systemic lupus erythematosus: all roads lead to type I interferons.
Curr Opin Immunol. 2006 Dec;18(6):676-82. doi: 10.1016/j.coi.2006.09.014. Epub 2006 Oct 2.
9
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice.
Immunity. 2006 Sep;25(3):429-40. doi: 10.1016/j.immuni.2006.07.014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验